FI924019A - Menetelmä vesipitoisen suspensiovalmisteen tuottamiseksi - Google Patents

Menetelmä vesipitoisen suspensiovalmisteen tuottamiseksi Download PDF

Info

Publication number
FI924019A
FI924019A FI924019A FI924019A FI924019A FI 924019 A FI924019 A FI 924019A FI 924019 A FI924019 A FI 924019A FI 924019 A FI924019 A FI 924019A FI 924019 A FI924019 A FI 924019A
Authority
FI
Finland
Prior art keywords
preparation
less
producing
aqueous suspension
diameter
Prior art date
Application number
FI924019A
Other languages
English (en)
Swedish (sv)
Other versions
FI924019A0 (fi
FI98890C (fi
FI98890B (fi
Inventor
Eric Willem Ackerman
Rene Jacobus Elisabert Grouls
Hendrikus Hubertus Mar Korsten
Original Assignee
Ziekenhuis Stichting Catharina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ziekenhuis Stichting Catharina filed Critical Ziekenhuis Stichting Catharina
Publication of FI924019A publication Critical patent/FI924019A/fi
Publication of FI924019A0 publication Critical patent/FI924019A0/fi
Application granted granted Critical
Publication of FI98890B publication Critical patent/FI98890B/fi
Publication of FI98890C publication Critical patent/FI98890C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI924019A 1990-03-20 1992-09-08 Menetelmä vesipitoisen suspensiovalmisteen tuottamiseksi FI98890C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
NL9000634A NL9000634A (nl) 1990-03-20 1990-03-20 Suspensie-injectiepreparaat op waterbasis, werkwijze voor de bereiding daarvan en toepassing van dit preparaat voor pijnbestrijding.
NL9000634 1990-03-20
PCT/NL1991/000042 WO1991014455A1 (en) 1990-03-20 1991-03-20 Aqueous suspension preparation for injection, method for producing the same and use thereof for producing pain relief
NL9100042 1991-03-20

Publications (4)

Publication Number Publication Date
FI924019A true FI924019A (fi) 1992-09-08
FI924019A0 FI924019A0 (fi) 1992-09-08
FI98890B FI98890B (fi) 1997-05-30
FI98890C FI98890C (fi) 1997-09-10

Family

ID=19856770

Family Applications (1)

Application Number Title Priority Date Filing Date
FI924019A FI98890C (fi) 1990-03-20 1992-09-08 Menetelmä vesipitoisen suspensiovalmisteen tuottamiseksi

Country Status (15)

Country Link
US (1) US5346903A (fi)
EP (1) EP0521070B1 (fi)
JP (1) JPH05507466A (fi)
AT (1) ATE121631T1 (fi)
AU (1) AU646857B2 (fi)
BR (1) BR1100601A (fi)
CA (1) CA2077641C (fi)
DE (1) DE69109279T2 (fi)
DK (1) DK0521070T3 (fi)
ES (1) ES2074269T3 (fi)
FI (1) FI98890C (fi)
GR (1) GR3015940T3 (fi)
NL (1) NL9000634A (fi)
NO (1) NO300114B1 (fi)
WO (1) WO1991014455A1 (fi)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206267A (en) * 1991-05-09 1993-04-27 Morton Shulman Pain controlling composition and method of preparation
US5635540A (en) * 1994-12-09 1997-06-03 The University Of Virginia Patent Foundation Stabilized topical pharmaceutical preparations
US6077545A (en) * 1995-10-30 2000-06-20 Matrix Pharmaceuticals, Inc. Process and composition for therapeutic cisplatin (CDDP)
EP0910369B1 (en) * 1996-03-26 2010-04-21 Eli Lilly And Company Benzothiophenes, formulations containing same, and methods
US6835194B2 (en) * 1999-03-18 2004-12-28 Durect Corporation Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
US6541021B1 (en) * 1999-03-18 2003-04-01 Durect Corporation Devices and methods for pain management
US7074803B2 (en) * 2001-03-02 2006-07-11 Durect Corporation Opioid formulations
JP2004527573A (ja) * 2001-04-24 2004-09-09 パーデュー・リサーチ・ファウンデーション 哺乳類の神経組織損傷の治療のための方法及び組成物
US20030181426A1 (en) * 2002-02-11 2003-09-25 Eisenach James C. Compositions and methods for treating pain using cyclooxygenase-1 inhibitors
US7838034B2 (en) 2002-07-30 2010-11-23 Grunenthal Gmbh Intravenous pharmaceutical form of administration
DE10234784A1 (de) * 2002-07-30 2004-02-19 Günenthal GmbH Intravenös applizierbare, pharmazeutische Darreichungsform
US20040102476A1 (en) * 2002-11-25 2004-05-27 Chan Tai Wah High concentration formulations of opioids and opioid derivatives
NZ554885A (en) * 2002-12-31 2009-07-31 Altus Pharmaceuticals Inc Complexes of hgh crystals and protamine polymers
EP2460530A3 (en) * 2002-12-31 2012-08-29 Althea Technologies, Inc. Human growth hormone crystals and methods for preparing them
GB0300531D0 (en) 2003-01-10 2003-02-12 West Pharm Serv Drug Res Ltd Pharmaceutical compositions
EP1976551A4 (en) * 2005-12-23 2009-12-30 Altus Pharmaceuticals Inc COMPOSITIONS COMPRISING COMPLEX PROTEIN CRYSTALS BY POLYCATIONS AND PROCESSING METHOD THEREOF
EP2120869A2 (en) * 2006-12-18 2009-11-25 Altus Pharmaceuticals Inc. Human growth hormone formulations
FI20075091A0 (fi) * 2007-02-09 2007-02-09 Kim Lemberg Noroksimorfoni käytettäväksi lääkeaineena
WO2008106571A2 (en) * 2007-02-28 2008-09-04 Abbott Laboratories Sustained release parenteral formulations of buprenorphine
US9125867B2 (en) * 2010-02-24 2015-09-08 Invincible Biotechnology Diversion- and/or abuse-resistant compositions and methods for making the same
US9272044B2 (en) 2010-06-08 2016-03-01 Indivior Uk Limited Injectable flowable composition buprenorphine
GB2513060B (en) * 2010-06-08 2015-01-07 Rb Pharmaceuticals Ltd Microparticle buprenorphine suspension
GB201404139D0 (en) 2014-03-10 2014-04-23 Rb Pharmaceuticals Ltd Sustained release buprenorphine solution formulations
DK3215223T3 (da) 2014-11-07 2020-08-03 Indivior Uk Ltd Buprenorphindoseringsskemaer
US10646484B2 (en) 2017-06-16 2020-05-12 Indivior Uk Limited Methods to treat opioid use disorder
WO2022175977A1 (en) * 2021-02-18 2022-08-25 Navin Saxena Research And Technology Private Limited A biodegradable implant composition and process for long term delivery of buprenorphine and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB784659A (en) * 1954-11-26 1957-10-16 Upjohn Co Therapeutic compositions and aqueous suspensions thereof
US3337406A (en) * 1963-12-12 1967-08-22 Mar Sal Inc Treatment of arteriosclerotic diseases
EP0031603A1 (en) * 1979-12-31 1981-07-08 American Cyanamid Company Pharmaceutical composition of matter
US4963367A (en) * 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
US4599354A (en) * 1985-03-11 1986-07-08 Morton Shulman Composition and method for producing prolonged pain relief

Also Published As

Publication number Publication date
DE69109279D1 (de) 1995-06-01
WO1991014455A1 (en) 1991-10-03
DE69109279T2 (de) 1995-11-09
ATE121631T1 (de) 1995-05-15
ES2074269T3 (es) 1995-09-01
CA2077641C (en) 2001-07-03
FI924019A0 (fi) 1992-09-08
NL9000634A (nl) 1991-10-16
AU646857B2 (en) 1994-03-10
EP0521070A1 (en) 1993-01-07
JPH05507466A (ja) 1993-10-28
FI98890C (fi) 1997-09-10
NO300114B1 (no) 1997-04-14
BR1100601A (pt) 2000-04-18
EP0521070B1 (en) 1995-04-26
CA2077641A1 (en) 1991-09-21
DK0521070T3 (da) 1995-05-22
US5346903A (en) 1994-09-13
FI98890B (fi) 1997-05-30
GR3015940T3 (en) 1995-07-31
AU7558091A (en) 1991-10-21
NO923429L (no) 1992-09-17
NO923429D0 (no) 1992-09-03

Similar Documents

Publication Publication Date Title
FI98890B (fi) Menetelmä vesipitoisen suspensiovalmisteen tuottamiseksi
IL115878A0 (en) Small particle formation
DK0577215T3 (da) Fremgangsmåde til fremstilling af overflademodificerede anticancer-nanopartikler
DK0787112T3 (da) Aerogelholdig sammensætning, fremgangsmåde til dens fremstilling samt dens anvendelse
ATE149828T1 (de) Arzneistofformulierung zur parenteralen anwendung
ZA929161B (en) Microcrystalline cellulose spheronization composition.
MY110186A (en) The use of tyloxapol as a nanoparticle stabilizer and dispersant.
DE69309052D1 (de) Oral anzuwendende suspension bestehend aus stabilisiertem rockenpulver eines hydratisierten cephalosporins
ES468301A1 (es) Procedimiento para la preparacion de una emulsion de sustan-cias medicamentosas para instilacion
DE69305346D1 (de) Zusammensetzung zur kontrollierten abgabe eines wirkstoffes und verfahren zur herstellung derselben
KR900007319A (ko) 살충 조성물
JPS5799521A (en) Solid composition containing bisacodyl
EP0048944A1 (en) An antimicrobial preparation
ES8506338A1 (es) Procedimiento de intensificar cultivos agricolas y similares
CA1038761A (en) Composition for controlling sexual behavior of mammals
Guilloteau et al. MIBG and catecholamine storage in the brain: an in-vitro study
AU635948B2 (en) Liquid suspensions of nitrofurantoin
Parellada et al. Local anaesthetics imidazole and calcium
Byers et al. The Effect of Triton, A Surface-active Polyoxyethylene Ether, on the Development of Experimental Silicosis
JPS57154130A (en) Pharmaceutical composition having uterotonic activity
KR890014115A (ko) 4-(3-포스포노-2-프로페닐)-2-피페라진카르복실산의 신규한 용도
JPH01207231A (ja) 肝類洞小孔拡張・増加剤

Legal Events

Date Code Title Description
BB Publication of examined application
MA Patent expired